GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Debt-to-Revenue

Asymchem Laboratories Tianjin Co (SZSE:002821) Debt-to-Revenue : 0.03 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Asymchem Laboratories Tianjin Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥43 Mil. Asymchem Laboratories Tianjin Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥101 Mil. Asymchem Laboratories Tianjin Co's annualized Revenue for the quarter that ended in Mar. 2024 was ¥5,599 Mil. Asymchem Laboratories Tianjin Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.03.


Asymchem Laboratories Tianjin Co Debt-to-Revenue Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Debt-to-Revenue Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.01 0.09 0.01 0.02

Asymchem Laboratories Tianjin Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.03 0.03

Competitive Comparison of Asymchem Laboratories Tianjin Co's Debt-to-Revenue

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's Debt-to-Revenue falls into.



Asymchem Laboratories Tianjin Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Asymchem Laboratories Tianjin Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(40.763 + 106.486) / 7825.19
=0.02

Asymchem Laboratories Tianjin Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(42.673 + 100.9) / 5599.232
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Asymchem Laboratories Tianjin Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.
Executives
Xiao Yi Executives
Xu Xiang Ke Directors, executives
Zhou Yan Executives
Chen Chao Yong Executives
Huang Xiao Lian Executives
Yang Jing Director
Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines